Aggressive Lymphomas
News
Combo prolongs survival in lymphoma models
Combination treatment with 2 monoclonal antibodies (mAbs) has demonstrated preclinical efficacy against B-cell lymphomas, according to researchers...
Conference Coverage
ASCT or novel therapies in early relapsing follicular lymphoma?
NEW YORK – Should autologous stem cell transplantation or novel therapies be the next step when a patient with follicular lymphoma experiences...
News
Inhibitor exhibits activity against range of lymphomas
Preclinical research suggests the dual PI3K/mTOR inhibitor PQR309 has activity against several types of lymphoma and works well in combination...
News
CCSs have increased risk of hypertension
A study of childhood cancer survivors (CCSs) suggests these individuals have an increased risk of developing hypertension as adults. The CCSs...
Conference Coverage
CAR T-cells gain ground against hematologic cancers
New data from the ZUMA-1 and JULIET studies will be presented at ASH 2017.
News
Method identifies effective treatments for leukemias, lymphomas
An ex vivo drug screening method can reveal optimal therapies for patients with hematologic malignancies, according to research published in The...
Feature
CAR T-cell therapy: Moving from cost to value
Cost and value issues temper CAR T-cell therapy enthusiasm.
News
FDA expands approval of obinutuzumab
The US Food and Drug Administration (FDA) has expanded the approved use of obinutuzumab (Gazyva®). The drug is now approved for use in...
From the Journals
Rituximab key to survival after transplant for mantle cell lymphoma
The benefit of rituximab “stands out, and adds to the increasing body of evidence supporting this practice for all MCL patients after ASCT,...
Conference Coverage
NCI-MATCH: Nivolumab shows promising activity in noncolorectal cancers
Nivolumab has promising activity in mismatch repair–deficient noncolorectal cancers, according to preliminary findings from the NCI-MATCH trial....
News
Cancer drug costs increasing despite competition
Cancer drug costs in the US increase substantially after launch, regardless of competition, according to a study published in the Journal of...